A Single Ascending Dose Study of BMS-791325 in HCV Infected Subjects

NCT00664625 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis C

Interventions

DRUG: BMS-791325
DRUG: Placebo

Sponsor

Bristol-Myers Squibb